HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 08, August 2017 – Eye – the Window to your Soul       » Palm-Sized PCR Device for Rapid Real-Time Detection of Viruses       » Scientists Uncover New Mechanism for Diabetic Neuropathy       » China Enlists AI to Diagnose Breast Cancer       » Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore       » Guardian Partners with MyDoc to Address Singapore's Population Health Needs through Integrating Technology and Self-Care       » Database Boosts Shanghai's Technology Aim      
EYE on CHINA
2013 BIO Convention in China to connect biotech industry to the world's 2nd largest biopharmaceutical market
The Biotechnology Industry Organization (BIO) announced the 3rd annual BIO® Convention in China, a sister event to the BIO International Convention that will bring together executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia to meet and explore business opportunities in China, now the 2nd largest biopharmaceutical market in the world. The event will take place November 11–13, 2013 at the China National Convention Center in Beijing, China.

China has designated the biotechnology industry as one of seven pillar industries in its 12th Five Year Plan. Now in its 4th year, the Chinese government is dramatically expanding its resources for innovative biopharma research and development. This focus has been reflected in a dramatic expansion of Chinese companies in-licensing of Western-originated projects, with the number of in-licensing projects this year already exceeding the number of in-licenses, joint ventures (JVs) and mergers and acquisitions (M&A) last year.

“As China becomes a major force in the pharmaceutical market, the number of Chinese and Western collaborations has increased exponentially,” said Alan Eisenberg, Executive Vice President, Emerging Companies & Business Development at BIO. “As we prepare for the third BIO® Convention in China, we are more excited than ever about the opportunities that exist in China and are eager to provide the biotech industry with a platform to engage this quickly expanding biopharmaceutical market.”

Preliminary program topics for the 3rd annual BIO® Convention in China include science-focused sessions such as vaccines as well as the research and development of orphan drugs to treat rare diseases in China, and business-focused sessions exploring China's private health care industry, early-stage VC funding in China, and partnering models between Chinese and Western companies.

The 2013 BIO® Convention in China will also feature one-on-one dialogues with biopharma industry executives who will discuss recent company successes, what keeps company executives up at night, and where the industry's leading companies are headed in 2014.

Click here for the complete issue.

NEWS CRUNCH  
news Vitafoods Asia 2017 heralds a new future of innovation
news Sanner receives Zero Defect Award
news AdAlta pioneers novel drug for rare lung disease
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy